Convatec Sustainability Profile
Convatec Group Plc, headquartered in Great Britain, is a leading global medical technology company specialising in advanced wound care, ostomy care, continence and critical care, and infusion devices. Founded in 1978, Convatec has established itself as a pioneer in the healthcare industry, focusing on innovative solutions that enhance patient outcomes. With a strong presence in Europe, North America, and Asia-Pacific, Convatec offers a diverse range of products, including hydrocolloid dressings and advanced ostomy appliances, known for their quality and effectiveness. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in healthcare. Convatec's dedication to improving the lives of patients and healthcare professionals alike underscores its reputation as a market leader in medical technology.
DitchCarbon Score
How does Convatec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Convatec's score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Convatec's reported carbon emissions
In 2024, Convatec reported carbon emissions of approximately 2,702,000 kg CO2e for Scope 1 emissions in Great Britain. Globally, their total emissions reached about 13,823,000 kg CO2e, with Scope 1 emissions at approximately 12,360,000 kg CO2e, Scope 2 emissions at about 1,463,000 kg CO2e, and Scope 3 emissions at approximately 239,255,000 kg CO2e. Convatec has set ambitious climate commitments, aiming for net zero emissions by 2045. They have also committed to reducing absolute Scope 1 and 2 greenhouse gas emissions by 70% by 2030, using 2021 as the base year. Additionally, they plan to cut Scope 3 emissions from purchased goods and services, upstream transportation, and waste generated in operations by 52% per sold product within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Convatec's commitment to addressing climate change within the healthcare equipment and supplies sector. The company is actively working towards these goals, demonstrating a proactive approach to sustainability and environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 4,001,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 26,805,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Convatec's Industry?
How Carbon Intensive is Convatec's Location?
Convatec's Scope 3 Categories Breakdown
Convatec's Scope 3 emissions, which decreased by 3% last year and decreased by approximately 10% since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the primary emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
Convatec's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Convatec has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
B. Braun Melsungen AG
Abbott
Boston Scientific
Frequently Asked Questions
Common questions about Convatec's sustainability data and climate commitments